D'ANGELO, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 688
EU - Europa 610
AS - Asia 149
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.454
Nazione #
US - Stati Uniti d'America 687
IE - Irlanda 264
UA - Ucraina 100
GB - Regno Unito 72
CN - Cina 70
IT - Italia 67
SG - Singapore 38
TR - Turchia 30
GR - Grecia 29
FI - Finlandia 25
BE - Belgio 17
DE - Germania 16
HU - Ungheria 6
SE - Svezia 5
ES - Italia 4
IN - India 4
AU - Australia 3
IR - Iran 3
KR - Corea 2
SC - Seychelles 2
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
FR - Francia 1
IQ - Iraq 1
JP - Giappone 1
NL - Olanda 1
PL - Polonia 1
Totale 1.454
Città #
Dublin 264
Jacksonville 154
Chandler 152
Beijing 46
Princeton 33
Roxbury 33
Medford 29
Woodbridge 28
Ann Arbor 26
Wilmington 21
Ashburn 17
Singapore 17
Brussels 13
Des Moines 12
Napoli 10
Düsseldorf 9
Mountain View 8
Caserta 7
Budapest 6
Jinan 6
Venice 6
Redwood City 5
Afragola 4
Auburn Hills 4
Cambridge 4
Gerpinnes 4
Lanzhou 4
Munich 4
Norwalk 4
Los Angeles 3
Seattle 3
Shenyang 3
Sydney 3
Acerra 2
Boardman 2
Florence 2
Giugliano in Campania 2
Kunming 2
Lancaster 2
Lappeenranta 2
Nanjing 2
Naples 2
Torino 2
Venezia 2
Washington 2
Zhengzhou 2
Aiello Del Sabato 1
Airola 1
Ankara 1
Bremen 1
Brno 1
Castellammare Di Stabia 1
Conil De La Frontera 1
Dallas 1
Gorgan 1
Groningen 1
Guangzhou 1
Haikou 1
Hebei 1
Isfahan 1
Juiz de Fora 1
La Laguna 1
La Spezia 1
Marbella 1
New Delhi 1
Ottawa 1
Perugia 1
Positano 1
Shaoxing 1
Somma Vesuviana 1
Tübingen 1
Wroclaw 1
Yuseong-gu 1
Totale 995
Nome #
Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers 74
Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises 71
A decoy oligonucleotide to NF-κB delivered through inhalable particles prevents LPS-induced rat airway inflammation 64
Core–shell hybrid nanocapsules for oral delivery of camptothecin: formulation development, in vitro and in vivo evaluation 63
Core-shell nanocarriers for cancer therapy. Part I: Biologically oriented design rules 60
Improving the efficacy of inhaled drugs in cystic fibrosis: Challenges and emerging drug delivery strategies 58
Pulmonary drug delivery: A role for polymeric nanoparticles? 58
Nanoparticles based on PLGA: Poloxamer blends for the delivery of proangiogenic growth factors 57
beta-Cyclodextrin Nanosponges as Multifunctional Ingredient in Water-Containing Semisolid Formulations for Skin Delivery 52
PEgylated polyester-based nanoncologicals 50
PLGA carriers for inhalation: Where do we stand, where are we headed? 50
Microsphere-integrated collagen scaffolds for tissue engineering: Effect of microsphere formulation and scaffold properties on protein release kinetics 49
Skin transport of PEGylated poly(ε-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-β-cyclodextrin 49
Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles 48
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors 48
Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres 45
Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: The role of heparin sodium salt and the PLGA-based microsphere approach 44
Engineering poly(ethylene oxide) buccal films with cyclodextrin: A novel role for an old excipient? 43
Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology 42
Overcoming barriers in Pseudomonas aeruginosa lung infections: Engineered nanoparticles for local delivery of a cationic antimicrobial peptide 41
Poly(ethylene oxide)/hydroxypropyl-β-cyclodextrin films for oromucosal delivery of hydrophilic drugs 40
Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB 39
Microparticle-embedded fibroin/alginate beads for prolonged local release of simvastatin hydroxyacid to mesenchymal stem cells 39
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections 37
Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections 36
Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier 35
In vitro/in vivo investigation on the potential of Pluronic® mixed micelles for pulmonary drug delivery 32
Improving in vivo conversion of oleuropein into hydroxytyrosol by oral granules containing probiotic Lactobacillus plantarum 299v and an Olea europaea standardized extract 28
Poly(lactide- co-glycolide) Nanoparticles for Prolonged Therapeutic Efficacy of Esculentin-1a-Derived Antimicrobial Peptides against Pseudomonas aeruginosa Lung Infection: In Vitro and in Vivo Studies 26
Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference? 25
Mucoadhesive zein/beta-cyclodextrin nanoparticles for the buccal delivery of curcumin 24
Alcohol-Based Hand Sanitizers: Does Gelling Agent Really Matter? 19
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles 15
Boosting lung accumulation of gallium with inhalable nano-embedded microparticles for the treatment of bacterial pneumonia 14
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases 14
Transmucosal delivery of the medical Cannabis oil via a nanoemulsion formulation 8
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: Antibacterial Activity and Toxicity In Vitro and In Vivo 8
State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives 6
The Questionable Quality Profile of Food Supplements: The Case of Red Yeast Rice Marketed Products 5
Enhancing transmucosal delivery of CBD through nanoemulsion: in vitro and in vivo studies 2
Totale 1.518
Categoria #
all - tutte 6.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 27 0 1 27 3 38 5 31 7 5 1
2020/2021209 1 1 23 5 49 2 30 23 10 22 29 14
2021/2022173 1 1 1 1 66 1 8 5 6 3 12 68
2022/2023503 34 2 5 48 41 57 0 28 258 6 12 12
2023/2024165 26 9 5 7 64 1 4 4 0 3 7 35
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.518